Caricamento...
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market
BACKGROUND: Our study estimated insurance payments and patient out-of-pocket (OOP) expenses associated with discarded weight-based intravenous antineoplastic drugs for privately insured US adult patients with cancer. METHODS: We identified patients who received weight-based antineoplastic drugs from...
Salvato in:
| Pubblicato in: | JNCI Cancer Spectr |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8328094/ https://ncbi.nlm.nih.gov/pubmed/34350376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkab045 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|